W.E. Owens
Research Subjects
W.E. Owens has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
C.H. Ray
Mastitis Research Laboratory|Hill Farm Research Station|Louisiana State University Agricultural Center
2 shared publicationsR.L. Boddie
Mastitis Research Laboratory, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Homer 71040, USA
2 shared publicationsS.C. Nickerson
Mastitis Research Laboratory|Hill Farm Research Station|Louisiana State University Agricultural Center
2 shared publicationsG.M. Tomita
USDA, ARS, LPSI, IDRL Building 173 BARC-East, Beltsville, MD 20705
1 shared publicationN.T. Boddie
Mastitis Research Laboratory|Hill Farm Research Station|Louisiana State University Agricultural Center
1 shared publicationW. Allen Nipper
1 shared publication
Latest Publications
- Open Access
- 1 February 2008
- Published by American Registry of Professional Animal Scientists in The Professional Animal Scientist
- Vol. 24 (1) , 103-106
Development of a Mycoplasma Mastitis Control Program in Louisiana
- 1 February 2008
- Published by American Registry of Professional Animal Scientists in The Professional Animal Scientist
- Vol. 24 (1) , 103-106
Open AccessDevelopment of a Mycoplasma Mastitis Control Program in Louisiana
- Open Access
- 1 August 2002
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 85 (8) , 1909-1912
Germicidal Activities of Representatives of Five Different Teat Dip Classes Against Three Bovine Mycoplasma Species Using a Modified Excised Teat Model
Six representative teat dips from five different teat dip classes were tested for germicidal activity against challenge exposure to Mycoplasma bovis, Mycoplasma californicum, and Mycoplasma bovigenitalium using a modified excised teat model. All teat dip formulations tested were efficacious against all of the Mycoplasma species, providing bacterial logarithmic reductions above 4. The germicides performed best against M. bovigenitalium with an average log reduction (LR) of 6.29. Average LR were 5.41 and 5.70 against M. bovis and M. californicum, respectively. The iodine and chlorhexidine products performed best against M. bovis and M. californicum, respectively, with complete kill of all organisms. The chlorhexidine and the barrier chlorine product also had complete kill of M. bovigenitalium organisms.
- 1 August 2002
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 85 (8) , 1909-1912
Open AccessGermicidal Activities of Representatives of Five Different Teat Dip Classes Against Three Bovine Mycoplasma Species Using a Modified Excised Teat Model
Six representative teat dips from five different teat dip classes were tested for germicidal activity against challenge exposure to Mycoplasma bovis, Mycoplasma californicum, and Mycoplasma bovigenitalium using a modified excised teat model. All teat dip formulations tested were efficacious against all of the Mycoplasma species, providing bacterial logarithmic reductions above 4. The germicides performed best against M. bovigenitalium with an average log reduction (LR) of 6.29. Average LR were 5.41 and 5.70 against M. bovis and M. californicum, respectively. The iodine and chlorhexidine products performed best against M. bovis and M. californicum, respectively, with complete kill of all organisms. The chlorhexidine and the barrier chlorine product also had complete kill of M. bovigenitalium organisms.
- Open Access
- 1 April 2001
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 84 (4) , 814-817
Prevalence of Mastitis in Dairy Heifers and Effectiveness of Antibiotic Therapy
Dairy heifers were treated 0 to 90 d, 90 to 180 d, or 180 to 270 d prepartum with one of five different antibiotic products to determine the best time and with which product they should be treated prior to calving. Two hundred thirty-three heifers were included in the study. At the initial sampling, 56.5% of quarters were infected with some type of organism and 15.4% of quarters were infected with Staphylococcus aureus. Treatments included a cephapirin dry cow product, a penicillin-novobiocin dry cow product, a penicillin-streptomycin dry cow product, an experimental dry cow product containing tilmicosin, and a cephalonium dry cow product not available in the United States. Cure rates for the five antibiotic products indicated that all were equally effective against Staph. aureus and all were significantly more effective than the spontaneous cure rate observed in untreated control quarters. No differences in efficacy were observed due to the different treatment times prepartum. However, fewer new Staph. aureus infections occurred after treatment in the group treated at 180 to 270 d prepartum, indicating that treatment in the third trimester will reduce the chances of new intramammary infections occurring after treatment and persisting to calving.
- 1 April 2001
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 84 (4) , 814-817
Open AccessPrevalence of Mastitis in Dairy Heifers and Effectiveness of Antibiotic Therapy
Dairy heifers were treated 0 to 90 d, 90 to 180 d, or 180 to 270 d prepartum with one of five different antibiotic products to determine the best time and with which product they should be treated prior to calving. Two hundred thirty-three heifers were included in the study. At the initial sampling, 56.5% of quarters were infected with some type of organism and 15.4% of quarters were infected with Staphylococcus aureus. Treatments included a cephapirin dry cow product, a penicillin-novobiocin dry cow product, a penicillin-streptomycin dry cow product, an experimental dry cow product containing tilmicosin, and a cephalonium dry cow product not available in the United States. Cure rates for the five antibiotic products indicated that all were equally effective against Staph. aureus and all were significantly more effective than the spontaneous cure rate observed in untreated control quarters. No differences in efficacy were observed due to the different treatment times prepartum. However, fewer new Staph. aureus infections occurred after treatment in the group treated at 180 to 270 d prepartum, indicating that treatment in the third trimester will reduce the chances of new intramammary infections occurring after treatment and persisting to calving.